| Breaking the circulus vitiosus of neuroinflammation: Resveratrol attenuates the human glial cell response to cytokines L Schlotterose, F Cossais, R Lucius, K Hattermann Biomedicine & Pharmacotherapy 163, 114814, 2023 | 8 | 2023 |
| Magnesium-lithium thin films for neurological applications–An in vitro investigation of glial cytocompatibility and neuroinflammatory response K Bhat, L Schlotterose, L Hanke, H Helmholz, E Quandt, K Hattermann, ... Acta Biomaterialia 178, 307-319, 2024 | 4 | 2024 |
| Resveratrol mitigates metabolism in human microglia cells L Schlotterose, MS Pravdivtseva, F Ellermann, O Jansen, JB Hövener, ... Antioxidants 12 (6), 1248, 2023 | 4 | 2023 |
| Traumatic Brain Injury in a Well: A Modular Three-Dimensional Printed Tool for Inducing Traumatic Brain Injury In vitro L Schlotterose, M Beldjilali-Labro, G Schneider, O Vardi, K Hattermann, ... Neurotrauma Reports 4 (1), 255-266, 2023 | 2 | 2023 |
| Resveratrol Alleviates the Early Challenges of Implant-Based Drug Delivery in a Human Glial Cell Model L Schlotterose, F Cossais, R Lucius, K Hattermann International Journal of Molecular Sciences 25 (4), 2078, 2024 | | 2024 |
| Inducing Mechanical Stimuli to Tissues Grown on a Magnetic Gel Allows Deconvoluting the Forces Leading to Traumatic Brain Injury L Schlotterose, M Beldjilali-Labro, M Hagel, M Yadid, C Flaxer, E Flaxer, ... Neurotrauma Reports 4 (1), 560-572, 2023 | | 2023 |
| Breaking the circulus vitiosus of neuroinflammation; resveratrol modulates the activation of human glial cells during cytokine-induced neuroinflammation L Schlotterose, F Cossais, R Lucius, K Hattermann GLIA 71, E819-E819, 2023 | | 2023 |
| An in-vitro oxygen-glucose-deprivation model to investigate the challenges of implant-based drug delivery for human glia cells L Schlotterose, F Cossais, M Voss, K Hattermann-Koch JOURNAL OF NEUROCHEMISTRY 162, 117-118, 2022 | | 2022 |
